Bryce Tenbarge

Bryce Tenbarge is the Senior Vice President of Commercial at Progenics Pharmaceuticals. Bryce has been with the company since August 2016, and in that time has served as the Chief Commercial Officer and Senior Vice President. Bryce is responsible for managing the commercial organization and business development for Progenics, and reports directly to the CEO.

Bryce has played a key role in the success of Progenics, leading the team that secured NTAP status for Azedra, and establishing a successful supply chain and delivery solution for the company's time-sensitive therapeutic drug. Under their leadership, Progenics has launched its first new product in 30 years. Bryce is a dedicated and passionate leader, with a proven track record of success in the pharmaceutical industry.

Bryce Tenbarge has a MBA in Business Administration and Management, General from the University of Michigan - Stephen M. Ross School of Business.

They are on a team with Benedict Osorio - Chief Operating Officer, Asha Das - Chief Medical Officer, and Jessica Jensen - Senior Vice President, Clinical Development. Bryce Tenbarge reports to David W. Mims, Intermin CEO .